Janet Hoogstraate on Sweden’s role in global biomanufacturing
Sweden has built a strong foundation in life science, with world-class research environments, advanced infrastructure, and skilled professionals. In a recent interview with SwedenBIO, our CEO, Janet Hoogstraate, shared her thoughts on how these strengths can be better promoted to attract international pharmaceutical projects.
Janet chairs SwedenBIO’s working group for process development and manufacturing where she challenges the notion that innovation stands on its own, emphasizing that production is what makes it real.
While Sweden is rightly proud of its research excellence, she emphasized the importance of keeping manufacturing in the country to ensure that research investments translate into therapies, jobs, and long-term value for society.
She called for clearer national goals in Sweden’s life science strategy, especially around advanced therapy production and clinical trials. Supporting companies that manufacture in Sweden, whether directly or through partners, helps strengthen the entire ecosystem.
NorthX Biologics is proud to contribute to this effort and to help bring innovation to life through production.